Quad by MEDVi Review: What the Site Publishes

Men’s health › Quad by MEDVi

BalanzGM is reader-supported — we may earn a commission from links on this page, at no extra cost to you. See our affiliate disclosure. This article is information, not medical advice.

What this page is. A description of Quad by MEDVi built from the company’s own published pages in August 2026. We have not given this service a rating. We could not establish, from their site, which formula a customer actually receives — their landing pages give two different ingredient lists for the same product — and we found no contraindication information anywhere on the Quad funnel. A score would imply we had assessed something we were unable to assess.

Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary.

Quad at a glance

What it isA compounded sublingual liquid for male sexual performance, marketed as a “4-in-1” formula and sold through direct-response landing pages
How you get itAn online intake form the site describes as three minutes, reviewed by a US-licensed doctor “within 24 hours”
Who reviews itAt parent-company level MEDVi names OpenLoop Health and CareGLP Affiliated P.C.s. The Quad pages themselves name no clinician group
Claimed profileOnset 10–15 minutes, duration up to 36 hours, sublingual liquid
DeliveryFree rush shipping, plain packaging
PricingOn the MEDVi site, with one-month and three-month plan structures

The ingredient question — read this before anything else

MEDVi runs several landing pages for Quad. They do not describe the same product.

PageIngredients stated
The main Quad pagePT-141 · L-citrulline · sildenafil · tadalafil
Two further variants of the main pageSame four
The /start pageApomorphine · vardenafil · tadalafil · sildenafil
An alternate home pageApomorphine · vardenafil · sildenafil · tadalafil
A third variantApomorphine · vardenafil · sildenafil · tadalafil, and separately also references L-citrulline — five, on one page

These are not small differences. One version contains two PDE5 inhibitors plus a melanocortin agonist and an amino acid. The other contains three PDE5 inhibitors plus a dopamine agonist. Those are different products with different interaction profiles, sold under one brand name.

What this means for you. If you order Quad, ask in writing which formulation you will receive before you pay. Which page you happened to land on should not determine which molecules arrive at your door, and from the outside there is no way to tell.

No milligram strengths are published for any ingredient on any Quad page we loaded.

What the site says about PT-141

On the pages that list it, PT-141 appears as a benefit line — “PT-141 – Ignites Desire.” Nothing else is said about it.

For context the site does not supply: PT-141 is bremelanotide, a melanocortin receptor agonist. It is FDA-approved under the brand name Vyleesi, and that approval is for hypoactive sexual desire disorder in premenopausal women. Use in men is not an approved indication. That is a reasonable thing for a prospective customer to know and it is not on the page.

How ordering works

  1. Complete the online intake form — described as three minutes.
  2. A US-licensed doctor reviews it, with a stated turnaround of 24 hours.
  3. If approved, the medication ships with free rush shipping in plain packaging.
  4. Billing runs on a subscription; the pages advertise “cancel anytime” alongside one-month and three-month plans.
State rules differ, and MEDVi does not publish a list. Their terms state: “The Services are currently available to individuals located in certain states. To see the list of current states, please contact customer service.” Some states require a live consultation before a prescription can be issued; the Quad pages describe a form-only flow and the medical consent page does not say whether a Quad visit is asynchronous or live. If this matters to you, ask before paying.

What to know before you order

We could not find any contraindication information

This is the most important line on this page. We looked for the standard PDE5 inhibitor warnings on the Quad funnel — nitrates, guanylate cyclase stimulators such as riociguat, cardiovascular cautions, priapism, a side-effect list, any “who should not use this” section. We checked nine Quad landing and upsell pages plus the parent site’s home, terms, medical consent and refund pages. We found none of it. The only risk-adjacent sentence is a general prompt to “speak with their provider about the specific risks and benefits.”

A PDE5 inhibitor combined with a nitrate in any form — including recreational nitrites sold as poppers — is contraindicated and can cause a dangerous fall in blood pressure. For a product containing two or three PDE5 inhibitors, that warning belongs somewhere a buyer will see it. We cannot rule out that screening questions appear inside the intake form itself, which is script-driven and did not render for us; what we can say is that nothing is disclosed before you reach it.

If you take any nitrate, or use poppers, do not order this product without speaking to a clinician first. The full contraindication list is in our label comparison.

Compounded, and framed unusually

MEDVi describes Quad as “a ‘Compound Medication.’ It is professionally formulated by US pharmacists and prescribed by licensed doctors specifically to ensure the dosages are safe, effective, and tailored to your history.” They also note that “MEDVi does not produce compounded medications, and individuals may receive medication that looks different than what is portrayed on the website.”

Worth noticing what is absent: the Quad pages carry no statement that compounded medications are not FDA-approved. That disclosure does exist on the parent site, but only in relation to their GLP-1 products. The framing on the Quad funnel — formulated “to ensure the dosages are safe, effective” — reads in the opposite direction from the standard disclosure, which is that compounded drugs are not evaluated by the FDA for safety, effectiveness or quality. See compounded vs brand-name for what that distinction means.

Billing terms contradict each other

The refund policy sets cancellation notice at 72 hours before the next billing date and describes a full refund if you cancel within 72 hours of starting with no services received. It also states, in capitals, that no refund is issued for the month in which cancellation occurs, and that other than medical disqualification “in no event shall you be issued a refund upon cancellation.”

The terms page says something different: “We cannot accept returns of prescription products for reuse or resale, and all sales are final”, with medical consult fees “not subject to or eligible for a refund”, and specifies no notice period at all.

The terms also impose binding arbitration with a class-action waiver, with a 30-day opt-out window.

The pharmacies are named — but not on the Quad pages

To MEDVi’s credit, the parent site names three: Triad Rx (Daphne, Alabama), RedRock Pharmacy (St. George, Utah) and Beaker Pharmacy & Compounding (McKinney, Texas). That is more disclosure than several competitors offer. The Quad funnel itself says only “we are partnered with multiple USA certified pharmacies.” No 503A or 503B designation is stated.

The rating on the page is not linked to a source

Quad pages display “Excellent 4.5 out of 5” attributed to Trustpilot, alongside “verified results from 50,000+ men.” No link to the Trustpilot profile is provided and we were not able to load the underlying page to check the figure. We are not repeating it as fact.

Who should not use it

Not for everyone. PDE5 inhibitors are contraindicated with nitrates in any form and with guanylate cyclase stimulators such as riociguat. They require caution with alpha-blockers, and the FDA labels advise against treating ED at all in men for whom sexual activity is inadvisable on cardiovascular grounds. An erection lasting more than four hours, sudden vision loss or sudden hearing loss all require immediate medical attention. Because MEDVi does not publish this information, you will need to bring it to the conversation yourself.

How we assessed this

We do not test prescription services and we did not become a patient. This description is based on MEDVi’s own published pages read in August 2026 — nine Quad landing and upsell pages, plus the parent site’s home page, terms, medical consent and refund policy — together with the FDA prescribing information for the molecules involved, following our review methodology. Where their pages disagreed with each other we have shown both. Where we could not find something, we have said where we looked.

Frequently asked questions

What is actually in Quad?

That depends which of their pages you read, which is the problem. Ask them directly and get the answer in writing before ordering.

Is it FDA-approved?

No. It is a compounded product, and compounded medications are not FDA-approved and are not evaluated by the FDA for safety, effectiveness or quality.

Which states does MEDVi serve?

They do not publish a list. Their terms direct you to contact customer service.

Is there a video consultation?

The marketing pages describe a form-only process. The medical consent page mentions video capability but does not say whether a Quad visit uses it.

Bottom line

Quad is marketed on speed and simplicity, and the funnel delivers both. What it does not deliver is the information a person needs to take a prescription medication safely: a single consistent ingredient list, any dose strengths, a state list, or the nitrate contraindication that applies to every product in this class. The pharmacies being named is a genuine point in their favour. If you are considering this service, the conversation to have first is with a clinician, not with the order form.

Looking at Quad by MEDVi?

Ask which formulation you will receive, and check the nitrate question, before you pay.

Visit Quad by MEDVi

Medical disclaimer. This article is for general information only and is not medical advice. It is not intended to diagnose, treat, cure or prevent any condition. Prescription treatments require evaluation by a US-licensed clinician, who decides whether treatment is appropriate for you. Talk to your own healthcare provider before starting, stopping or changing any medication. Never combine a PDE5 inhibitor with any nitrate. Individual results vary.

Published August 2026 · Last reviewed August 2026 · Editorial policy · About BalanzGM

Balanzgm Editorial Team
Balanzgm Editorial Team

BalanzGM is an independent editorial publication that reviews direct-to-consumer health services and products sold to readers in the United States — telehealth weight-loss and men's health programs, and hemp-derived wellness products. We research each provider from material anyone can check for themselves: the provider's own published information and terms, FDA records and prescribing information, third-party lab documentation and certifications where they exist, and aggregated customer feedback from verified retailers and public review platforms. We do not conduct first-person product testing and we are not a clinical or scientific testing laboratory. Nothing we publish is medical advice. We disclose every affiliate relationship clearly and never accept paid placements.

BalanzGM
Logo